Your browser doesn't support javascript.
loading
Comprehensive structural analysis reveals broad-spectrum neutralizing antibodies against Omicron
Xiangyang Chi; Lingyun Xia; Guanying Zhang; Ximin Chi; Bangdong Huang; Yuanyuan Zhang; Zhengshan Chen; Jin Han; Liushu Wu; Zeya Li; Hancong Sun; Ping Huang; Changming Yu; Wei Chen; Qiang Zhou.
Affiliation
  • Xiangyang Chi; Institute of Biotechnology
  • Lingyun Xia; Westlake University
  • Guanying Zhang; Institute of Biotechnology
  • Ximin Chi; Westlake University
  • Bangdong Huang; Westlake University
  • Yuanyuan Zhang; Westlake University
  • Zhengshan Chen; Institute of Biotechnology
  • Jin Han; Institute of Biotechnology
  • Liushu Wu; Westlake University
  • Zeya Li; Institute of Biotechnology
  • Hancong Sun; Institute of Biotechnology
  • Ping Huang; Institute of Biotechnology
  • Changming Yu; Institute of Biotechnology
  • Wei Chen; Institute of Biotechnology
  • Qiang Zhou; Westlake University
Preprint in English | bioRxiv | ID: ppbiorxiv-509344
ABSTRACT
The pandemic of COVID-19 caused by SARS-CoV-2 continues to spread around the world. Mutant strains of SARS-CoV-2 are constantly emerging. At present, Omicron variants have become mainstream. In this work, we carried out a systematic and comprehensive analysis of the reported spike protein antibodies, counting the antibodies epitopes and genotypes. We further comprehensively analyzed the impact of Omicron mutations on antibody epitopes and classified these antibodies according to their binding patterns. We found that the epitopes of one class of antibodies were significantly less affected by Omicron mutations than other classes. Binding and virus neutralization experiments show that such antibodies can effectively inhibit the immune escape of Omicron. Cryo-EM results show that this class of antibodies utilizes a conserved mechanism to neutralize SARS-CoV-2. Our results greatly help us deeply understand the impact of Omicron mutations. At the same time, it also provides guidance and insights for developing Omicron antibodies and vaccines.
License
cc_no
Full text: Available Collection: Preprints Database: bioRxiv Type of study: Systematic review Language: English Year: 2022 Document type: Preprint
Full text: Available Collection: Preprints Database: bioRxiv Type of study: Systematic review Language: English Year: 2022 Document type: Preprint
...